• Hero Banner
  • ACVCACVC
  • DVM 360
  • Fetch DVM 360Fetch DVM 360
DVM 360
dvm360 | Veterinary News, Veterinarian Insights, Medicine, Pet Care
dvm360 | Veterinary News, Veterinarian Insights, Medicine, Pet Care
By Role
AssociatesOwnersPractice ManagerStudentsTechnicians
Subscriptions
dvm360 Newsletterdvm360 Magazine
News
All News
Association
Breaking News
Education
Equine
FDA
Law & Ethics
Market Trends
Medical
Products
Recalls
Regulatory
Digital Media
dvm360 LIVE!™
Expert Interviews
The Vet Blast Podcast
Medical World News
Pet Connections
The Dilemma Live
Vet Perspectives™
Weekly Newscast
dvm360 Insights™
Publications
All Publications
dvm360
Firstline
Supplements
Top Recommended Veterinary Products
Vetted
Clinical
All Clinical
Anesthesia
Animal Welfare
Behavior
Cardiology
CBD in Pets
Dentistry
Dermatology
Diabetes
Emergency & Critical Care
Endocrinology
Equine Medicine
Exotic Animal Medicine
Feline Medicine
Gastroenterology
Imaging
Infectious Diseases
Integrative Medicine
Nutrition
Oncology
Ophthalmology
Orthopedics
Pain Management
Parasitology
Pharmacy
Surgery
Toxicology
Urology & Nephrology
Virtual Care
Business
All Business
Business & Personal Finance
Buying or Selling a Practice
Hospital Design
Leadership & Personal Growth
Personnel Management
Practice Finances
Practice Operations
Technology
Wellbeing & Lifestyle
Continuing Education
Conferences
Live Conferences
Conference News
Conference Proceedings
Resources
CBD in Pets
Contests
Veterinary Heroes
Partners
Spotlight Series
Team Meeting in a Box
Toolkit
Top Recommended Veterinary Products
Vet to Vet
  • Contact Us
  • Fetch DVM360 Conference
  • Terms and Conditions
  • Privacy
  • Do Not Sell My Information
  • About Us

© 2023 MJH Life Sciences and dvm360 | Veterinary News, Veterinarian Insights, Medicine, Pet Care. All rights reserved.

Advertisement
By Role
  • Associates
  • Owners
  • Practice Manager
  • Students
  • Technicians
Subscriptions
  • dvm360 Newsletter
  • dvm360 Magazine
  • Contact Us
  • Fetch DVM360 Conference
  • Terms and Conditions
  • Privacy
  • Do Not Sell My Information
  • About Us
  • MJHLS Brand Logo

© 2023 MJH Life Sciences™ and dvm360 | Veterinary News, Veterinarian Insights, Medicine, Pet Care. All rights reserved.

Intervet gets USDA nod for three-year canine vaccine

May 1, 2005

Millsboro, Del. — Intervet introduces Continuum DAP, the first and only canine vaccine approved by the United States Department of Agriculture (USDA) for a three-year duration-of-immunity against distemper, adeno virus and parvovirus.

MILLSBORO, DEL. — Intervet introduces Continuum DAP, the first and only canine vaccine approved by the United States Department of Agriculture (USDA) for a three-year duration-of-immunity against distemper, adeno virus and parvovirus.

Intervet gets USDA nod for three-year canine vaccine

Continuum DAP allows veterinarians to adhere to the American Animal Hospital Association triennial vaccination guidelines for core vaccines involving three serious and potentially deadly diseases, the company says.

Dr. Sebastian Huron, director of Intervet's Companion Animal Business Team, says of the introduction, "It's not all about a product, it's about a new concept in the way we vaccinate."

Advertisement

The vaccine contains attenuated strains of canine distemper virus (CDV), adenovirus type 2 and parvovirus.

Continuum DAP was evaluated based on the Code of Federal Regulations (CFR) criteria for both serologic and real-time efficacy results.

"Veterinarians can feel confident that they are practicing the best medicine for dogs by providing 100 percent protection over three years," Huron says.

The product has been evaluated in dogs with challenge-of-immunity testing methodologies, which are considered the gold standard for evaluating vaccine efficacy.

To evaluate the efficacy of the vaccine, vaccinated dogs were compared with age-matched controls challenged three years following initial vaccination, the company says.

The product was released at the April AAHA meeting in Baltimore.

For fastest response, call

(800) 441-8272

www.continuum3.com.

Related Content:

Regulatory
Feed control officials reassert copper concentration guidelines
Feed control officials reassert copper concentration guidelines
What's going on with xylazine becoming a street drug?
What's going on with xylazine becoming a street drug?
USDA aims to strengthen handling regulations for exotic animals in exhibition
USDA aims to strengthen handling regulations for exotic animals in exhibition

Advertisement

Latest News

Locoregional analgesia for pain management in veterinary medicine

Outside toxicology experts can save pets’ lives

Lyon College School of Veterinary Medicine names founding dean

Morris Animal Foundation funds study on environmental toxins and lymphoma

View More Latest News
Advertisement